Advancing excellence in laboratory medicine for better healthcare worldwide

Doctor Sandra QUIJANO selected to receive the 2020 IFCC Distinguished Women Scientist Award for Contribution to In Vitro Diagnostics


Milan, 24 April 2020
- The IFCC, the international leading organization in the field of Clinical Chemistry and Laboratory Medicine, is pleased to announce that Dr. Sandra QUIJANO (Department of Microbiology, Faculty of Sciences Pontificia Universidad Javeriana, Bogotá - Colombia), has been selected to receive the 2020 IFCC Distinguished Women Scientist Award For Contribution To In Vitro Diagnostics, sponsored by Yashraj Biotechnology Ltd. This award recognizes a woman who has made significant contributions to the development or utilization of In Vitro Diagnostics with emphasis on applications in primary healthcare. The award will be presented for the first time on occasion of the WorldLab Congress to be held in Seoul in 2021.

The IFCC is very pleased to acknowledge the support from Yashraj Biotechnology Ltd in the recognition of scientists and educators with a distinguished career in this area.

Dr. Quijano is a Bacteriologist graduated from the Pontificia Universidad Javeriana Bogotá-Colombia, with a Master's Degree in Microbiology from the Pontificia Universidad Javeriana Bogotá-Colombia, Master in Cellular and Molecular Oncology from the National Center for Oncology Research CNIO Madrid-Spain and Doctor in Biology and Cancer Clinic from the University of Salamanca, Salamanca-Spain. Sandra worked for 10 years in the Immunology Group of the National Cancer Institute in Bogotá, and with her work group pioneered the immunophenotypic study of leukemia and lymphomas by immunohistochemistry in samples of bone marrow, peripheral blood and lymph nodes of patients with these diseases and in the study of leukemia by flow cytometry, giving way to the first developments of the immunophenotyping of hematological tumors in Colombia.

Prof. Maurizio FERRARI, IFCC President and Chair IFCC Awards Committee, said: "We are delighted in selecting Dr. Sandra Quijano for the IFCC Distinguished Women Scientist Award for Contribution to In Vitro Diagnostics. She has a remarkable career in the field of clinical chemistry and laboratory medicine, and she is an example for the new generations of laboratory professionals because of her determination, resilience and perseverance in achieving their goals. I really believe that Dr Quijano is a most worthy recipient of the IFCC Distinguished Women Scientist Award For Contribution To In Vitro Diagnostics”.

The 2020 IFCC Awardees are a witness of the contribution that IFCC gives to advancement of excellence in laboratory medicine for better healthcare worldwide. Doctor Quijano, along with nine other IFCC Distinguished Award winners will be formally announced on Wednesday 6th January 2021 at the Opening Ceremony of the 24th WorldLab - IFCC International Congress in Clinical Chemistry and Laboratory Medicine to be held in Seoul (South Korea) from 6th to 10th January 2021.

- end -
click here to download the press release

ABOUT IFCC

IFCC is the leading organization in the field of Clinical Chemistry and Laboratory Medicine worldwide. Through leadership and innovation in science and education, IFCC strives to enhance the scientific level and the quality of diagnosis and therapy for patients throughout the world. IFCC builds on the professionalism of its members to provide quality services to patients. IFCC is a Federation of 93 Full Member and 17 Affiliate member Societies of Clinical Chemistry and Laboratory Medicine representing more than 45.000 individual clinical chemists, laboratory scientists, and laboratory physicians and 48 Corporate Members covering the major areas of clinical laboratory developments. For further details please contact: ifcc@ifcc.org.

 


ABOUT Yashraj Biotechnology Ltd

We are a research and innovation driven, ISO 13485:2016, ISO 9001:2015 and OHSAS 18001:2007 certified company, established in 1999 at Navi Mumbai, Maharashtra, India. We have operations in Germany, USA and will soon establish presence in South Korea. Our research, development and production-related activities encompass a whole range of native, recombinant and cell-derived antigens; and monoclonal antibodies. Highest standards of quality and unwavering commitment towards healthcare innovation have enabled us to capture some of the biggest market segments for various biomarker antigens and antibodies. Visit: https://www.yashraj.com/

 
Website developed by Insoft